Non-clinical safety of GRAd vector-based COVID-19 and HIV vaccines supports a platform regulatory approach
Reji Paalangara, Stéphanie Gohin, Alexis Menard, Charlotte Amy, Wahiba Berrabah, Alexandra Rogue, Matthew A. Getz, Aljawharah Alrubayyi, Simone Battella, Angelo Raggioli, Michela Gentile, Anthea Di Rita, Alessia Noto, Giuseppina Miselli, Fabiana Grazioli, , Stefania Capone
This study evaluates the non-clinical safety of two GRAd vector-based vaccines for COVID-19 and HIV, showing consistent safety profiles and supporting a regulatory platform approach.
Vaccines · Feb 6, 2026Peer-reviewedPharmacology & Toxicology